Soleno Therapeutics stock dips on proposed $200M offering

10 hours ago 2

Soleno Therapeutics (NASDAQ:SLNO) shares fell nearly 10% premarket on Thursday after the company proposed an offering of $200 million of shares of its common stock.

In addition, the biopharmaceutical company intends to grant the underwriters a 30-day option to purchase up

Recommended For You

More Trending News

Read Entire Article